Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
1.
Support Care Cancer ; 31(12): 643, 2023 Oct 18.
Artigo em Inglês | MEDLINE | ID: mdl-37851104

RESUMO

INTRODUCTION: High-intensity interval training (HIIT) is an appropriate training modality to improve endurance and therefore contributes to physical performance. This review investigates the effect of HIIT on functional performance in cancer patients. We reviewed the relative peak oxygen uptake (relV̇O2PEAK) and meta-analytical compared HIIT with moderate intensity continuous training (MICT). Furthermore, we took various training parameters under consideration. METHODS: A systematic literature search was conducted in Scopus, PubMed, and Cochrane Library databases. For the review, we included randomized controlled trials containing HIIT with cancer patients. From this, we filtered interventions with additional MICT for the meta-analysis. Outcomes of interest were various functional performance assessments and V̇O2MAX. RESULTS: The research yielded 584 records which fit the inclusion criteria, of which 31 studies with n=1555 patients (57.4±8.6 years) could be included in the overall review and 8 studies in the meta-analysis (n=268, 59.11±5.11 years) regarding relV̇O2PEAK. Different functional outcomes were found, of which walking distance (+8.63±6.91% meters in 6-min walk test) and mobility (+2.7cm in sit and reach test) improved significantly due to HIIT. In terms of relV̇O2PEAK, the performance of cancer patients was improved by HIIT (10.68±6.48%) and MICT (7.4±4.29%). HIIT can be favored to increase relV̇O2PEAK (SMD 0.37; 95% CI 0.09-0.65; I2=0%; p=0.009). Effect sizes for relV̇O2PEAK improvements correlate moderately with total training volume (Spearman's ρ=0.49; p=0.03), whereas percentage increases do not (Spearman's ρ=0.24; p=0.14). CONCLUSION: Functional and physical outcomes were positively altered by different HIIT protocols and forms of implementation, whereas a tendency toward more effectiveness of HIIT vs. MICT was found for relV̇O2PEAK. Future studies should include functional parameters more often, to finally allow a comparison between both training protocols in this regard.


Assuntos
Treinamento Intervalado de Alta Intensidade , Neoplasias , Humanos , Treinamento Intervalado de Alta Intensidade/métodos , Consumo de Oxigênio , Estado Nutricional , Desempenho Físico Funcional , Oxigênio , Neoplasias/terapia
2.
Br J Oral Maxillofac Surg ; 56(9): 881-886, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-30360905

RESUMO

We know of no current published data on the prevalence of craniosynostosis in Germany, so our objective in this study was to contribute to the limited knowledge of its epidemiology by assessing time trends, the frequency of prenatal diagnosis, and the timing of diagnosis and treatment. Data were collected in Saxony-Anhalt during the period 2000-17, and we designed a retrospective multicentre cohort study. The prevalence was 4.8 cases of craniosynostosis/10 000 births, and did not increase during that time. We compared the data of 91 patients with those of 273 controls. There were 75 boys and 16 girls (ratio 4.7:1). Fifty-one children had isolated craniosynostosis, consisting of 46 with a single-suture, and five with a multisuture, synostosis. Twenty-nine were associated with other congenital malformations, and 11 were syndromic. Three cases had been diagnosed prenatally, and 34 had skull deformities diagnosed immediately after birth at a mean (SD) age of 3.4 (4.7) months. The mean (SD) age at the time of first admission to hospital in one of the three surgical centres of Saxony-Anhalt was 5.9 (5.5) months, and 65 patients were operated on at a mean age of 9.1 (6.3) months. In contrast to published reports we found a prevalence of 4.8 cases of craniosynostosis/10 000 births that did not increase during the period 2000-16. Although we found a low prenatal detection rate, the diagnosis and treatment in this cohort study seemed timely.


Assuntos
Craniossinostoses/epidemiologia , Anormalidades Múltiplas/diagnóstico , Anormalidades Múltiplas/epidemiologia , Anormalidades Múltiplas/cirurgia , Craniossinostoses/diagnóstico , Craniossinostoses/cirurgia , Feminino , Alemanha/epidemiologia , Humanos , Recém-Nascido , Masculino , Prevalência , Estudos Retrospectivos
3.
Horm Metab Res ; 48(8): 529-34, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27388431

RESUMO

Levels of vascular endothelial growth factors (VEGF) are regulated in a complex network of adipokines, glucose control, and low grade inflammation together with activated platelets, leucocytes, and endothelial dysfunction. Increased levels of VEGF are associated with enhanced angiogenesis and impaired repair mechanisms of vascular lesions in endorgans. Little is known about the interaction of systemic VEGF levels with quality of diabetes control, biomarkers of inflammation, and diabetic nephropathy. Moreover, it is unclear, whether serum and plasma VEGF levels are similarly suited to reflect risk associated with VEGF.In this case control study, we analyzed these parameters in serum and plasma of age and sex matched controls without diabetes (n=99) and type 2 diabetes (n=302). Serum VEGF-A was significantly increased in patients with T2DM while plasma levels were in the same range as for controls. Individual levels varied in a wide range. Serum levels were 4.9 times higher in controls and 7.3 times higher in T2DM as compared to plasma levels. T2DM was associated with significantly higher levels of hsCRP, ALAT, and albumin/creatinine ratio. When calculated for tertiles of HbA1c, we observed a highly significant increase from tertile one to the upper tertile for serum VEGF-A but not for plasma VEGF-A. Correlation analysis revealed a significant relationship between VEGF-A, HbA1c, inflammation, and diabetic nephropathy. Our results indicate that increased VEGF-A levels in T2DM significantly depend on quality of HbA1c control. Serum levels of VEGF-A, with a strong contribution of platelet derived VEGF, better reflect the glycemic burden than plasma levels of VEGF-A. Mechanistic studies are needed to explore links to inflammation and diabetic nephropathy.


Assuntos
Biomarcadores/sangue , Glicemia/metabolismo , Nefropatias Diabéticas/sangue , Inflamação/sangue , Fator A de Crescimento do Endotélio Vascular/sangue , Idoso , Proteína C-Reativa/metabolismo , Estudos de Casos e Controles , Demografia , Diabetes Mellitus Tipo 2/sangue , Nefropatias Diabéticas/complicações , Feminino , Hemoglobinas Glicadas/metabolismo , Humanos , Hiperglicemia/sangue , Hiperglicemia/complicações , Inflamação/complicações , Modelos Lineares , Masculino , Microvasos/patologia , Fatores de Risco
4.
Klin Padiatr ; 226(4): 243-7, 2014 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-25010130

RESUMO

Interdisciplinary cooperation and networking determine the success of activities for supporting families at risk for early childhood abuse. The integration of the healthcare sector might be important.The medical standard of perinatal care at the University hospital includes information exchange about family risk factors which may contribute to an increased risk of child abuse within the first year of life. As a result, the -pediatrician offered supporting services for the families at the time of the second examination during the official childhood health screening program (U2). A team of family-sponsorship was established and evaluated.In 281 of 1238 risk-factor questionnaires at least one stress factor was detected and 97 families had high-impact family stress. Families under the supervision of a family midwife or youth services had a significantly higher number of risk factors. The family-sponsorship program was institutionalized and positively evaluated by the families.The time of a hospital delivery is an excellent opportunity for the evaluation of familial risk factors and for the provision of supporting services. To increase the acceptance of such services by the families at risk repeated assessment of risk factors and support offers are required.


Assuntos
Maus-Tratos Infantis/prevenção & controle , Comportamento Cooperativo , Intervenção Médica Precoce , Acessibilidade aos Serviços de Saúde , Comunicação Interdisciplinar , Maus-Tratos Infantis/diagnóstico , Diagnóstico Precoce , Feminino , Alemanha , Humanos , Lactente , Recém-Nascido , Acontecimentos que Mudam a Vida , Masculino , Programas de Rastreamento , Equipe de Assistência ao Paciente , Fatores de Risco , Inquéritos e Questionários
5.
Gene Ther ; 20(11): 1104-9, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23804075

RESUMO

MicroRNA dysregulation often results in the development and progression of cancer. miR-143 is ubiquitously expressed in most human and murine tissues but downregulated in many cancer types. This differential miRNA expression can be utilized for targeted cancer gene therapies. Multiple copies of the miR-143 complementary target sequence were inserted into the 3'UTR of plasmid vectors encoding either for different reporter genes or for the therapeutic gene TNFα. With these transgenes, we analyzed the miR-143-dependent gene expression in cancer cells and normal cells. Moreover, we investigated miR-143-regulated luciferase expression in an NMRI nude/HUH7 xenograft mouse model using a nonviral carrier system for in vivo transfections. We showed low and high levels of miR-143 in cancer cells and normal cells, respectively, leading to a differential gene expression of the reporters and the therapeutic TNFα. According to the miR-143 levels, the luciferase reporter gene expression was silenced in the mouse lungs but not in HUH7 tumors. Thus, we utilized the differential miR-143 expression in healthy and cancerous tissues to de-target the lung by specifically targeting the tumor in an in vivo HUH7 xenograft mouse model. The use of an miR-143-regulated therapeutic transgene may present a promising approach for cancer gene therapy.


Assuntos
MicroRNAs/genética , MicroRNAs/metabolismo , Transgenes , Fator de Necrose Tumoral alfa/genética , Animais , Sítios de Ligação , Linhagem Celular Tumoral , Proliferação de Células , Feminino , Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Genes Reporter , Humanos , Pulmão/metabolismo , Camundongos , Camundongos Nus , Camundongos Transgênicos , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/terapia , Fator de Necrose Tumoral alfa/metabolismo , Ensaios Antitumorais Modelo de Xenoenxerto
6.
Klin Padiatr ; 224(6): 377-81, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23047832

RESUMO

BACKGROUND: In adult cancer patients the negative predictive value of elevated CRP levels has been described for several malignancies. Only few studies have analyzed the prognostic role of CRP in children and adolescents with classical HL. In these studies elevated CRP levels correlate with the presence of classical risk factors and adverse outcome. PATIENTS AND METHODS: The prognostic role of CRP for patients with classical HL admitted to the GPOH-HD-2002 study was analyzed retrospectively. RESULTS: CRP levels were documented for 369 of 573 patients. Significant (p<0.05) increased median CRP levels were found in the presence of B-Symptoms (25.7 vs. 5.1 mg/l), extranodal involvement (21.5 vs. 7.5 mg/l), elevated erythrocyte sedimentation rate (ESR, 13.0 vs. 1.0 mg/l) and stage III/IV disease (15.5 vs. 5.3 mg/l). 83.9% of patients with elevated and 45.8% of patients with normal CRP had an ESR >30 mm/h. CONCLUSION: Elevated CRP levels were associated with classical risk factors of HL. CRP and ESR may reflect different biological processes. CRP was prognostic within early stage TG-1 patients treated with reduced treatment, but not within advanced stage TG-2+3.


Assuntos
Biomarcadores Tumorais/sangue , Proteína C-Reativa/metabolismo , Doença de Hodgkin/sangue , Doença de Hodgkin/diagnóstico , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Sedimentação Sanguínea , Criança , Estudos de Coortes , Esquema de Medicação , Feminino , Seguimentos , Alemanha , Doença de Hodgkin/mortalidade , Doença de Hodgkin/patologia , Doença de Hodgkin/terapia , Humanos , Masculino , Estadiamento de Neoplasias , Prognóstico , Radioterapia Adjuvante , Estudos Retrospectivos , Fatores de Risco , Taxa de Sobrevida
8.
Klin Padiatr ; 224(3): 156-9, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22513795

RESUMO

Methotrexate (MTX) is commonly administered in high doses for treatment of childhood acute lymphoblastic leukemia (ALL). The aim of this analysis was to study the influence of 2 common MTHFR polymorphisms (MTHFR 677C>T and 1298 A>C) on MTX toxicity in children with ALL.Retrospective analysis of 129 MTX courses in 34 pediatric patients with ALL.677C>T variants (CT or TT) were found in 19 (14 heterozygous, 5 homozygous) and 1298A>C variants (AC or CC) in 20 (16 heterozygous, 4 homozygous) patients. The MTHFR 677C>T wild type was associated with an increased frequency of grade III and IV leukopenia (60% vs. 31%, p<0.05) compared to the variants. The rate of severe infections (21% vs. 0%, p<0.05) and grade III-IV anemia (26% vs. 5%, p<0.05) was increased in carriers of the MTHFR 677C>T wild type compared to patients with the TT variant. Grade III-IV anemia was more frequent in patients with the MTHFR 1298A>C CC variant compared to the wild type (56% vs. 21%, p<0.05). The differences were not significant in a patient-based analysis.MTX related toxicity might be influenced by the MTHFR 677C>T or the MTHFR 1298A>C polymorphisms. Differences in MTX toxicity are only partially explainable by these 2 polymorphisms.


Assuntos
Alelos , Antimetabólitos Antineoplásicos/toxicidade , Metotrexato/toxicidade , Metilenotetra-Hidrofolato Redutase (NADPH2)/genética , Polimorfismo Genético/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Antimetabólitos Antineoplásicos/farmacocinética , Antimetabólitos Antineoplásicos/uso terapêutico , Criança , Pré-Escolar , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Triagem de Portadores Genéticos , Genótipo , Homozigoto , Humanos , Leucopenia/induzido quimicamente , Leucopenia/genética , Masculino , Metotrexato/farmacocinética , Metotrexato/uso terapêutico , Projetos Piloto , Estudos Retrospectivos , Resultado do Tratamento
9.
HNO ; 60(2): 109-16, 2012 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-22331085

RESUMO

INTRODUCTION: Surgical accuracy in microscopic ear surgery is reduced by limited access and tremor. At this point a micromanipulator could have a positive influence. The goal of the study was: 1. To develop a system that would enable measurements of accuracy, time and precision during a manual approach to the middle ear 2. To apply a manipulator that can easily be a compact part of the regular setup in ear surgery 3. To compare the manual results critically considering accuracy and tremor reduction and to compare these results with those of a manipulator A manipulator in ear surgery does not need to be a highly complex structure with force feedback and multiple degrees of freedom. The surgeon's preparation in middle ear surgery is most of the time straight without potentially applying the 15 degrees of freedom the human hand can offer. The micromanipulator in this study was developed in order to serve as a compact, teleoperated instrument without limiting the surgeon's dexterity. The use of standard instruments facilitates the integration of the system in existing surgical procedures and sterilisation concepts. MATERIAL AND METHODS: Ten head and neck surgeons simulated an approach to the stapedial footplate on a modified 3D cast of a realistic human skull in an experimental OR. A perforator was moved to a reference point on the stapedial footplate. The movements were detected by means of an image acquisition system. Each trial was repeated more than 200 times, aiming both manually and with the aid of a micromanipulator (> 4,000 measurements). RESULTS: Accuracy for the manual and micromanipulator approach revealed no considerable differences. In absolute terms, the manual approach was more accurate. However, the learning curves indicated a stronger decrease in deviation when the micromanipulator was used and also less deviation in scatter plots. At the beginning, the time required for pointing increased when using the micromanipulator, but decreased to a greater extent in the course of the trial when compared to the manual approach. The work strain was distinctively lower when the micromanipulator was applied. CONCLUSION: The micromanipulator gave evidence of a stronger effect as regards individual improvement in accuracy and time span. The micromanipulator shows potential for improvements in accuracy as well as compensation for poor ergonomics.


Assuntos
Microcirurgia/instrumentação , Robótica/instrumentação , Cirurgia do Estribo/instrumentação , Timpanoplastia/instrumentação , Competência Clínica , Desenho de Equipamento , Humanos , Curva de Aprendizado , Manequins , Prótese Ossicular
10.
Klin Padiatr ; 223(3): 142-6, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21567369

RESUMO

BACKGROUND: The improving prognosis of children with cancer has partially been attributed to the increasing importance of pediatric intensive care units (PICU). We analyze whether outcome of these patients on a PICU improved during the last decade and which factors may influence the outcome in our hospital. PATIENTS AND METHODS: The charts of all oncology patients admitted to the PICU between 1998 and 2009 have been reviewed retrospectively. The survival of patients admitted for life threatening complications has been correlated with basic data, organ failure and the PRISM score. The results of 2 consecutive treatment periods (1998-2003 and 2004-2009) were compared. RESULTS: 644 admissions of 226 patients were recorded. 79 admissions were performed because of potentially life threatening complications (Group A), 236 for monitoring (B) and 329 admissions for interventions (C). 62% of Group A patients and all Group B and C patients were discharged alive. Poor outcome was associated with admission >28 days after initial diagnosis, PRISM >10, organ failure >2 organs, sepsis, allogeneic stem cell transplantation, need for mechanical ventilation or for catecholamines. The PICU survival rate of Group A patients admitted between 2004 and 2009 (78%) was higher than in the period between 1998 and 2003 (48%). CONCLUSIONS: PICU provides essential services to support the pediatric oncology ward. Although children with cancer may have had benefit from advances in pediatric intensive care over the past decade, specific scoring systems for early identification of children with cancer needing PICU treatment are required. These systems might further improve PICU outcome in critical ill pediatric cancer patients.


Assuntos
Unidades de Terapia Intensiva Pediátrica/estatística & dados numéricos , Neoplasias/complicações , Neoplasias/terapia , Admissão do Paciente/estatística & dados numéricos , Adolescente , Adulto , Anemia Aplástica/complicações , Anemia Aplástica/patologia , Anemia Aplástica/terapia , Causas de Morte , Criança , Pré-Escolar , Feminino , Seguimentos , Transplante de Células-Tronco Hematopoéticas/mortalidade , Mortalidade Hospitalar , Hospitais Gerais/estatística & dados numéricos , Hospitais Pediátricos/estatística & dados numéricos , Humanos , Lactente , Estimativa de Kaplan-Meier , Tempo de Internação/estatística & dados numéricos , Masculino , Síndromes Mielodisplásicas/complicações , Síndromes Mielodisplásicas/mortalidade , Síndromes Mielodisplásicas/terapia , Neoplasias/mortalidade , Prognóstico , Estudos Retrospectivos , Análise de Sobrevida , Adulto Jovem
11.
Stud Health Technol Inform ; 163: 524-30, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21335850

RESUMO

Manual accuracy in microsurgery is reduced by tremor and limited access. A surgical approach through the middle ear also puts delicate structures at risk, while the surgeon is often working at an unergonomic position. At this point a micromanipulator could have a positive influence. A system was developed to measure "working accuracy", time and precision during manipulation in the middle ear. 10 ENT-surgeons simulated a perforation of the stapedial footplate on a modified 3D print of a human skull in a mock OR. Each trial was repeated more than 200 times aiming manually and using a micro-manipulator. Data of over 4000 measurements was tested and graphically processed. Work strain was evaluated with a questionnaire. Accuracy for manual and micromanipulator perforation revealed a small difference. Learning curves showed a stronger decrease both in deviation and time when the micromanipulator was used. Also a lower work strain was apparent. The micromanipulator has the potential as an aiding device in ear surgery.


Assuntos
Sistemas Homem-Máquina , Microcirurgia/instrumentação , Modelos Biológicos , Robótica/instrumentação , Cirurgia do Estribo/instrumentação , Cirurgia Assistida por Computador/instrumentação , Interface Usuário-Computador , Simulação por Computador , Humanos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
12.
Nuklearmedizin ; 50(1): 22-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21165537

RESUMO

UNLABELLED: [¹8F]Fluoromisonidazole positron emission tomography (FMISO-PET) is a non invasive imaging technique that can assist detecting intra tumour regions of hypoxia. FMISO-PET evinces comparatively low signal-to-noise-ratio (SNR) and may be acquired dynamically or after different uptake times post injection (p.i.). The aim of this study was to identify, if static images acquired two hours (MISO2) or four hours (MISO4) p.i. reveal higher contrast. PATIENTS, METHODS: As part of a prospective trial, 23 patients with cancers of the head and neck underwent [¹8F]fluorodeoxyglucose (FDG) PET before and during curative radiochemotherapy. Additionally, FMISO-PET studies 2 h and 4 h p.i. were done before treatment and after a mean dose of 11Gy, 23 Gy and 57 Gy during RCT. After coregistration, a dedicated software was used to define the gross tumour volume (GTV) by FDG PET for the primary tumour. This volume was overlaid to the FMISO images and hypoxia within the GTV was determined. The contrast between hypoxia determined by MISO2 and by MISO4 was investigated and analysed with the Wilcoxon-matched-pairs test. RESULTS: Mean SUVmax in tumours of all examinations was 2.2 (stdev: 0.4, min: 1.3, max: 3.4) after 2 h and 2.4 (stdev: 0.7, min: 1.1, max: 4.4) after 4 h. In the neck musculature the mean SUVmax was 1.5 at both time points and the mean SUVmean decreased from 1.2 after 2 h to 1.1 after 4 h, respectively. These effects resulted in significantly rising contrast ratios from MISO2 to MISO4. The differently defined contrasts revealed significantly higher values for examinations 4 h p.i. (p < 0.002). CONCLUSION: Data acquisition of [¹8F]FMISO should be done 4 h p.i. to gather the optimal contrast, preferably allowing further analysis, e. g. hypoxic sub volume definition for therapy planning.


Assuntos
Carcinoma de Células Pequenas/diagnóstico por imagem , Neoplasias de Cabeça e Pescoço/diagnóstico por imagem , Aumento da Imagem/métodos , Misonidazol/análogos & derivados , Tomografia por Emissão de Pósitrons/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Misonidazol/administração & dosagem , Compostos Radiofarmacêuticos/administração & dosagem , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Fatores de Tempo
13.
Bone Marrow Transplant ; 45(3): 483-9, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19684633

RESUMO

We examined the role of total body magnetic resonance imaging (TB-MRI)-governed involved compartment irradiation (ICI) and high-dose chemotherapy (HDC), followed by stem cell rescue (SCR) in patients with high-risk Ewing tumors (ETs) with multiple primary bone metastases (high-risk ET-MBM). Eleven patients with high-risk ET-MBM receiving initial assessment of involved bones by TB-MRI were registered from 1995 to 2000 (group A). In all, 6 patients out of 11 had additional lung disease at initial diagnosis; all had multifocal bone disease with more than three bones involved. After systemic induction with etoposide, vincristine, adriamycin (doxorubicin), ifosfamide, and actinomycin D (EVAIA) or VAIA chemotherapy, ICI of all sites positive by TB-MRI was administered, followed by HDC and SCR. A second group matched for observation period and consisting of 26 patients with more than three involved bones at diagnosis was treated with the European Intergroup Cooperative Ewing Sarcoma Study-92 (EICESS-92) protocol (group B). These patients did not receive TB-MRI and consequently did not receive TB-MRI-governed ICI, or HDC and SCR. Survival in group A vs group B was 45 vs 8% at 5 years and 27 vs 8% at 10 years after diagnosis (log rank and Breslow: P<0.005). We conclude that TB-MRI-governed ICI followed by HDC and SCR in ET-MBM is feasible and warrants further evaluation in prospective studies.


Assuntos
Neoplasias Ósseas/terapia , Sarcoma de Ewing/terapia , Adolescente , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/radioterapia , Neoplasias Ósseas/secundário , Criança , Protocolos Clínicos , Terapia Combinada , Feminino , Transplante de Células-Tronco Hematopoéticas , Humanos , Estimativa de Kaplan-Meier , Imageamento por Ressonância Magnética , Masculino , Sarcoma de Ewing/tratamento farmacológico , Sarcoma de Ewing/radioterapia , Sarcoma de Ewing/secundário , Irradiação Corporal Total/métodos , Adulto Jovem
14.
Klin Padiatr ; 221(6): 374-8, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19890790

RESUMO

BACKGROUND: The risk of severe complications or death during the initial period of acute leukemia was markedly decreased due to the progress in pediatric oncology and use of simple measures like hyperhydration, forced diuresis, treatment of hyperuricemia, correction of electrolyte and coagulation disturbances and the careful use of antileukemic drugs. The incidence of leukostasis and tumor lysis syndrome depends on absolute initial white blood cell counts and the underlying type of leukemia. Leukapheresis or exchange transfusion may improve the prognosis of high risk patients. METHODS: Records of all pediatric patients who were newly diagnosed with acute leukemia between 1 / 1998 und 12 / 2008 were retrospectively reviewed for presence of hyperleukocytosis(white blood cell count > 100 GPT / l) at diagnosis and subsequent leukapheresis or exchange transfusion in regards to the clinical outcome. RESULTS: At diagnosis 11 (14 % ) of 77 children with acute leukemia (7 acute lymphoblastic leukemia / ALL; 4 acute myeloblastic leukemia /AML) had hyperleukocytosis. 4 patients (2 ALL, 2 AML) received exchange transfusion and 2 others (1 ALL, 1 AML) underwent leukapheresis. Marked cytoreduction was achieved in all patients within 24 h after therapy initiation. There were no procedure-related adverse events. Symptoms due to hyperleukocytosis markedly improved after cytoreduction. CONCLUSION: Leukapheresis or exchange transfusion together with conservative management and specific oncological therapy may contribute to rapid leukocyte reduction with acceptable risk. The exact impact of leukapheresis or exchange transfusion on short and long term outcome in pediatric patients with acute leukemia and initial hyperleukocytosis has to be evaluated in future multicentre studies or by the formation of clinical registries.


Assuntos
Transfusão Total , Leucaférese , Leucemia Mieloide Aguda/terapia , Leucocitose/terapia , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Criança , Pré-Escolar , Terapia Combinada , Intervalo Livre de Doença , Feminino , Humanos , Lactente , Leucemia Mieloide Aguda/diagnóstico , Leucemia Mieloide Aguda/mortalidade , Contagem de Leucócitos , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidade , Estudos Retrospectivos
15.
Z Geburtshilfe Neonatol ; 213(4): 161-3, 2009 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-19685409

RESUMO

Gentamicin is an aminoglycoside that is widely used in neonatology in spite of its known nephrotoxicity and ototoxicity. Because there are only few cases reported in the literature experience with gentamicin overdosage is limited. We report the case of a preterm (gestational age 32+2 weeks) infant with an accidental administration of a ten-fold dose of gentamicin. The baby was treated with a slight increase of fluid intake and monitoring of renal function and gentamicin levels, respectively. A rapid decrease of the gentamicin level (peak level 44.5 mg/L, extrapolated peak level 65 mg/L) was observed. Nephrotoxicity or ototoxicity did not occur. Because of the small number of described cases, a general recommendation for the management of gentamicin intoxication is not possible. The intensity of treatment depends on renal function and gentamicin level. Only isolated patients will need dialysis or exchange transfusion. The case also demonstrates the need for the continuous discussion about hospital-associated damage and error management systems.


Assuntos
Gentamicinas/intoxicação , Antibacterianos/administração & dosagem , Antibacterianos/intoxicação , Overdose de Drogas/terapia , Hidratação , Gentamicinas/administração & dosagem , Humanos , Recém-Nascido , Doenças do Recém-Nascido/tratamento farmacológico , Recém-Nascido Prematuro , Masculino , Erros Médicos/prevenção & controle , Sepse/tratamento farmacológico
16.
HNO ; 57(10): 999-1009, 2009 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-19690817

RESUMO

PROBLEM: This work presents a new training concept for surgery of the temporal bone. It is based on a model of gypsum plastic with optoelectric detection of risk structures. A prototypical evaluation is given. MATERIAL AND METHODS: The training models are based on high-resolution computed tomographic data of a human skull. The resulting data set was printed by a three-dimensional (3D) printer. A 3D phantom is created from gypsum powder and a bonding agent. Risks structures are the facial nerve, semicircular canal, cochlea, ossicular chain, sigmoid sinus, dura, and internal carotid artery. An electrically conductive metal (Wood's metal) and a fiber-optic cable were used as detection materials for the risk structures. For evaluating the training system, a study was done with eight inexperienced and eight experienced ear surgeons. They were asked to perform temporal bone surgery using two identical training models (group A). In group B, the same surgeons underwent surgical training with human cadavers. In the case of injuries, the number, point in time, degree (facial nerve), and injured structure were documented during the training on the model. In addition, the total time needed was noted. RESULTS: The training systems could be used in all cases. Evaluation of the anatomic accuracy of the models showed results that were between 49.5% and 90% agreement with the anatomic origin. Error detection was evaluated with values between 79% and 100% agreement with the perception of an experienced surgeon. The operating setting was estimated to be better than the previous"gold standard." The possibility of completely replacing the previous training method, which uses cadavers, with the examined training model was affirmed. CONCLUSIONS: This study shows that the examined system fulfills the conditions for a new training concept for temporal bone surgery. The system connects the preliminary work with printed and sintered models with the possibilities of microsystem engineering. In addition, the model's digital database permits a complete virtual representation of the model with appropriate further applications ("look behind the wall," virtual endoscopy).


Assuntos
Instrução por Computador/métodos , Orelha Média/cirurgia , Manequins , Osteotomia/educação , Procedimentos Cirúrgicos Otorrinolaringológicos/educação , Cirurgia Assistida por Computador/instrumentação , Cirurgia Assistida por Computador/métodos , Desenho de Equipamento , Análise de Falha de Equipamento , Alemanha , Humanos , Osteotomia/métodos , Procedimentos Cirúrgicos Otorrinolaringológicos/métodos
17.
Klin Padiatr ; 220(3): 189-95, 2008.
Artigo em Alemão | MEDLINE | ID: mdl-18478493

RESUMO

BACKGROUND: Sedation and analgosedation form part of the every-day work in the clinical care of pediatric patients. The American Academy of Pediatrics (AAP), the American Society of Anesthesiologists (ASA) and the German Society for Anesthesiology and Intensive Care (DGAI) have established guidelines outlining the general conditions for sedating/analgosedating measures. Since the provisions of the specialist associations diverge in some respects, we have developed an own standard. This takes into account the existing guidelines, aiming at maximum safety for our patients and maximum practicability. METHODS: In line with the guidelines of the above specialist societies and the international literature, we have developed a standard referring to the information of patients, eating and drinking, monitoring before, during and after the sedation/analgosedation as well as documentation. Over a 12-month period, this standard was applied to all sedations/analgosedations in our hospital which were not performed by the intensive care department. All measures were recorded in a protocol specifically designed for this purpose. RESULTS: In the twelve months under review, a total of 103 sedations/analgosedations were performed (39 of which for bone marrow puncture or punch biopsies, 27 for gastroscopies or coloscopies and 24 for arthrocenteses). None of the sedations or analgosedations implied complications endangering any of our patients. The standard applied proved to be practicable. It was only the documentation, which is closely related to anaesthesiologist protocols, which required adjustment from our staff initially. CONCLUSION: The standard we have developed and applied provides a practicable and safe protocol to regulate the preparation and monitoring of sedations and analgosedations for pediatric patients. A specific guideline to be issued by the Deutsche Gesellschaft für Kinder- und Jugendmedizin (German Pediatric Society) is considered desirable.


Assuntos
Medicina do Adolescente/educação , Sedação Consciente/normas , Educação de Pós-Graduação em Medicina/normas , Internato e Residência/normas , Pediatria/educação , Especialização , Adolescente , Benchmarking , Criança , Alemanha , Humanos , Guias de Prática Clínica como Assunto , Gestão da Segurança/normas
18.
Z Geburtshilfe Neonatol ; 209(4): 151-5, 2005 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-16138273

RESUMO

Birth injuries occur occasionally but, in contrast, perinatally acquired epidural and intracerebral hematomas as well as neonatal skull fractures are extremely rare. The appropriate diagnostic and therapeutic modalities depend on the size and site of the injury as well as any accompanying diseases. We report the case of a neonatal epidural and intracerebral haematoma with skull fracture following secondary caesarean section. There was no evidence for trauma during pregnancy, birth injury or other possible causes of bleeding. The haematoma was decompressed surgically. One year after surgery the boy suffers from moderate neurological compromise and focal seizures.


Assuntos
Traumatismos do Nascimento/diagnóstico , Hemorragia Cerebral/congênito , Cesárea , Hematoma Epidural Craniano/congênito , Osso Parietal/lesões , Fraturas Cranianas/congênito , Índice de Apgar , Traumatismos do Nascimento/cirurgia , Cardiotocografia , Hemorragia Cerebral/diagnóstico , Hemorragia Cerebral/cirurgia , Cistos/diagnóstico , Ecoencefalografia , Espaço Epidural , Epilepsias Parciais/etiologia , Feminino , Seguimentos , Síndrome de Adaptação Geral/diagnóstico , Gliose/diagnóstico , Hematoma Epidural Craniano/diagnóstico , Hematoma Epidural Craniano/cirurgia , Humanos , Lactente , Recém-Nascido , Osso Parietal/cirurgia , Gravidez , Fraturas Cranianas/diagnóstico , Fraturas Cranianas/cirurgia , Tomografia Computadorizada por Raios X
19.
Z Geburtshilfe Neonatol ; 208(1): 36-41, 2004 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-15039891

RESUMO

Thromboembolic events in neonates are very rare. They are often associated with severe disease affecting the newborn or are secondary to central venous lines or arterial catheters. Most of the described cases of thromboses of the iliac or femoral arteries are associated with cardiac catheterisation or femoral invasive blood pressure monitoring. The relationship between single umbilical arteries and an increased incidence of structural and chromosomal anomalies is well known, but a higher rate of thromboembolic disease in infants with single umbilical arteries has not been described. Rt-PA (recombinant tissue plasminogen activator) has been successfully used in small studies and numerous case reports. To date controlled clinical trials giving guidelines for antithrombotic therapy using rt-PA are still lacking. We report the clinical course of a 700 g premature male, who was born by Caesarean section at 29 + 6 gestational weeks. On the fifth day the baby suffered from arterial thrombosis of the right pelvis axis. Antenatally a single umbilical artery was identified. Iliac arteries on the involved site appeared hypoplastic. Additionally, the prothrombin G20210A mutation was found. The patient was treated successfully using recombinant tissue plasminogen activator. In the case of a high risk of limb or organ loss due to arterial thrombosis, thrombolysis using rt-PA is justified. Appropriate rt-PA treatment has been studied for the adult but not the paediatric population. Hence, well-designed clinical trials are necessary to determine the pharmacokinetics and dynamics of thrombolytic agents in children.


Assuntos
Artéria Ilíaca , Doenças do Prematuro/tratamento farmacológico , Terapia Trombolítica , Trombose/tratamento farmacológico , Ativador de Plasminogênio Tecidual/administração & dosagem , Síndrome de Dandy-Walker/diagnóstico , Síndrome de Dandy-Walker/genética , Retardo do Crescimento Fetal/diagnóstico , Retardo do Crescimento Fetal/genética , Triagem de Portadores Genéticos , Humanos , Artéria Ilíaca/anormalidades , Recém-Nascido , Isquemia/diagnóstico , Isquemia/tratamento farmacológico , Perna (Membro)/irrigação sanguínea , Masculino , Mutação/genética , Protrombina/genética , Proteínas Recombinantes/administração & dosagem , Trombose/genética , Ultrassonografia Doppler
20.
Klin Padiatr ; 215(4): 234-40, 2003.
Artigo em Alemão | MEDLINE | ID: mdl-12929015

RESUMO

BACKGROUND: As a result of improved therapeutic and diagnostic modalities the survival rate of children with neoplastic disease has increased dramatically. The consequences of these scientific advances have led to increased malignancy-related critical complications requiring the expertise of intensive care practitioners. PATIENTS: From all children admitted to the pediatric intensive care unit (PICU) of the Martin-Luther University Halle those with hematologic-oncologic condition were evaluated. RESULTS: From 4068 PICU admissions 196 (4.8%) oncologic patients were identified. Most of them were admitted for postoperative care, monitoring or intervention. 24 patients were admitted because of severe disease or treatment related complications. 14 out of 24 (58%) patients died on PICU. Mortality was significant higher in a subgroup requiring mechanical ventilation or suffering from sepsis. All patients but two with multi-organ system failure (> or = 2 organs) died. CONCLUSIONS: Children with neoplastic disease can benefit from pediatric intensive care unit (PICU) support. Successful treatment of life-threatening complications requires a close cooperation of pediatric oncology and PICU. Further studies are necessary to improve therapeutic strategies in oncology patients requiring PICU admission.


Assuntos
Unidades de Terapia Intensiva Pediátrica/estatística & dados numéricos , Neoplasias/terapia , Adolescente , Fatores Etários , Criança , Pré-Escolar , Feminino , Alemanha , Humanos , Lactente , Leucemia/complicações , Leucemia/mortalidade , Leucemia/terapia , Masculino , Insuficiência de Múltiplos Órgãos/diagnóstico , Insuficiência de Múltiplos Órgãos/etiologia , Neoplasias/complicações , Neoplasias/mortalidade , Fatores de Risco , Fatores Sexuais , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA